Anti-EPO Receptor (phospho Y485) antibody [EPR2266] (ab79824)

Overview

  • Product nameAnti-EPO Receptor (phospho Y485) antibody [EPR2266]
    See all EPO Receptor primary antibodies
  • Description
    Rabbit monoclonal [EPR2266] to EPO Receptor (phospho Y485)
  • Specificityab79824 only detects EPO Receptor phosphorylated at Tyrosine 485.
  • Tested applicationsSuitable for: WB, IPmore details
    Unsuitable for: Flow Cyt,ICC or IHC-P
  • Species reactivity
    Reacts with: Human
  • Immunogen

    A phospho specific peptide corresponding to residues surrounding Tyrosine 485 of human EPO Receptor.

  • Positive control
    • MCF-7 cell lysate treated with pervanadate.
  • General notes

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.

    Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.

Properties

Applications

Our Abpromise guarantee covers the use of ab79824 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/10000 - 1/50000. Detects a band of approximately 59 kDa (predicted molecular weight: 55 kDa).
IP 1/20.
  • Application notesIs unsuitable for Flow Cyt,ICC or IHC-P.
  • Target

    • FunctionReceptor for erythropoietin. Mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate the LYN tyrosine kinase.
      Isoform EPOR-T acts as a dominant-negative receptor of EPOR-mediated signaling.
    • Tissue specificityErythroid cells and erythroid progenitor cells. Isoform EPOR-F is the most abundant form in EPO-dependent erythroleukemia cells and in late-stage erythroid progenitors. Isoform EPOR-S and isoform EPOR-T are the predominant forms in bone marrow. Isoform EPOR-T is the most abundant from in early-stage erythroid progenitor cells.
    • Involvement in diseaseDefects in EPOR are the cause of erythrocytosis familial type 1 (ECYT1) [MIM:133100]. ECYT1 is an autosomal dominant disorder characterized by increased serum red blood cell mass, elevated hemoglobin and hematocrit, hypersensitivity of erythroid progenitors to erythropoietin, erythropoietin low serum levels, and no increase in platelets nor leukocytes. It has a relatively benign course and does not progress to leukemia.
    • Sequence similaritiesBelongs to the type I cytokine receptor family. Type 1 subfamily.
      Contains 1 fibronectin type-III domain.
    • DomainThe WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding.
      The box 1 motif is required for JAK interaction and/or activation.
      Contains 1 copy of a cytoplasmic motif that is referred to as the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is involved in modulation of cellular responses. The phosphorylated ITIM motif can bind the SH2 domain of several SH2-containing phosphatases.
    • Post-translational
      modifications
      On EPO stimulation, phosphorylated on C-terminal tyrosine residues by JAK2. The phosphotyrosine motifs are also recruitment sites for several SH2-containing proteins and adapter proteins which mediate cell proliferation. Phosphorylation on Tyr-454 is required for PTPN6 interaction, Tyr-426 for PTPN11. Tyr-426 is also required for SOCS3 binding, but Tyr-454/Tyr-456 motif is the preferred binding site.
      Ubiquitinated by NOSIP; appears to be either multi-monoubiquitinated or polyubiquitinated. Ubiquitination mediates proliferation and survival of EPO-dependent cells.
    • Cellular localizationCell membrane and Secreted. Secreted and located to the cell surface.
    • Information by UniProt
    • Database links
    • Alternative names
      • EPO R antibody
      • EPO-R antibody
      • epor antibody
      • EPOR_HUMAN antibody
      • Erythropoietin receptor antibody
      • Erythropoietin receptor precursor antibody
      • MGC138358 antibody
      see all

    Anti-EPO Receptor (phospho Y485) antibody [EPR2266] images

    • All lanes : Anti-EPO Receptor (phospho Y485) antibody [EPR2266] (ab79824) at 1/50000 dilution

      Lane 1 : MCF-7 cell lysate untreated
      Lane 2 : MCF-7 cell lysate treated with pervanadate

      Lysates/proteins at 10 µg per lane.

      Secondary
      Goat anti-rabbit HRP conjugate at 1/2000 dilution

      Predicted band size : 55 kDa
      Observed band size : 59 kDa (why is the actual band size different from the predicted?)

    References for Anti-EPO Receptor (phospho Y485) antibody [EPR2266] (ab79824)

    This product has been referenced in:
    • Chen AY  et al. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFa. PLoS Pathog 7:e1002088 (2011). WB . Read more (PubMed: 21698228) »
    • Cao Y  et al. Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance. Genes Cancer 1:50-61 (2010). Read more (PubMed: 20657792) »

    See all 2 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab79824.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"